Impact of Toll-like receptor signalling on urinary tract infection

International Journal of Antimicrobial Agents

Volumn 31, Issue SUPPL. 1, 2008, Pages 9-14

  Scherberich, Juergen E ^a   Hartinger, Anton ^b  

^a Staedt Klinikum Muenchen GmbH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Defence mechanisms; Escherichia coli; Kidney cells; TLR4; Toll like receptor; Urinary tract infection; Uropathogens; Virulence factors

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CPG OLIGODEOXYNUCLEOTIDE; FIMBRIA P PROTEIN; FIMBRIA PROTEIN; GLYCOLIPID; GLYCOPROTEIN; LIPOPEPTIDE; OLIGONUCLEOTIDE; SINGLE STRANDED RNA; TAMM HORSFALL GLYCOPROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; CELL ACTIVATION; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; KIDNEY TUBULE CELL; LEUKOCYTE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; TOLL-LIKE RECEPTORS; URINARY TRACT INFECTIONS;

EID: 38149117074     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.032     Document Type: Article

References (37)

1. Williams D.H., and Schaeffer A.J. Current concepts of urinary tract infections. Minerva Urol Nefrol 56 (2004) 15-31
2. Rice J.C., Peng T., Spence J.F., et al. Pyelonephritic Escherichia coli expressing P-fimbriae decrease immune response of the mouse kidney. J Am Soc Nephrol 16 (2005) 3583-3591
3. Scherberich J.E., Lissner R., Kachel H.-G., and Scheuermann E. Immunglobulin-Subklassen-Defizienz und veränderte monozytäre LPS-Rezeptor (CD14)-Expression bei Nierentransplantatempfängern: Beziehung zu chronischen Harnwegsinfekten. Nieren-u Hochdruckkrankh 25 (1996) 545-548
4. Cotran R.S. Interstitial nephritis. Monogr Pathol 20 (1979) 254-280
5. Aoki S., Imamura S., Aokli M., and McCabe W.R. 'Abacterial' and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med 28 (1969) 1375-1382
6. Scherberich J.E., Gauhl C., and Jüngst G. Bacterial adherence to brush border constituents of human kidney. In: Losse H., Asscher A.W., and Lison A.E. (Eds). Pyelonephritis vol. 4 (1980), Thieme-Stratton, New York, NY 72-81
7. Scherberich J.E. Chronic pyelonephritis. Synopsis of laboratory values and ultrasound lead to diagnosis. MMW Fortschr Med 141 (1999) 28-32 [in German]
8. Wullt B., Bergsten G., Connell H., et al. P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 3 (2001) 255-264
9. Fischer H., Yamamoto M., Akira S., Beutler B., and Svanborg C. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 36 (2005) 267-277
10. Svanborg C., Bergsten G., Fischer H., et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 9 (2006) 33-39
11. Frendeus B., Wachtler C., Hedlund M., et al. Escherichia coli P-fimbriae utilize the toll-like receptor 4 pathway for cell activation. Mol Microbiol 40 (2001) 37-51
12. Shimizu T., Yokota S., Takahashi S., et al. Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells. Clin Diagn Lab Immunol 11 (2004) 969-976
13. Anders H.-J., and Patole P.S. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract. Nephrol Dial Transplant 20 (2005) 1529-1532
14. Scherberich J.E., Kellermeyer M., and Hartinger A. 1-alpha-calcidol modulates major monocyte antigens and toll-like receptors TLR2 and TLR4 in vitro. Eur J Med Res 10 (2005) 179-182
15. Scherberich J.E., Nockher W.A., and Baer P.C. Cross-talk between activated tubular epithelia of human kidney and monocytes: a basis for target cell-specific pharmacotherapy?. Nephrol Dial Transplant 14 Suppl. 4 (1999) 8-10
16. Nockher W.A., and Scherberich J.E. Expression and release of the monocyte LPS receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 158 (1997) 1345-1352
17. Scherberich J.E., and Nockher W.A. CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med 37 (1999) 209-213
18. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., and Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167 (2001) 1882-1885
19. El-Achkar T.M., and Dagher P.C. Renal Toll-like receptors: recent advances and implications for disease. Nat Clin Pract Nephrol 10 (2006) 568-581
20. El-Achkar T.M., Huang X., Plotkin Z., Sandoval R.M., Rhodes G.J., and Dagher P.C. Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 290 (2005) F1034-F1043
21. Zhang D., Zhang G., Hayden M.S., et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303 (2004) 1522-1526
22. Hedlund M., Frendeus B., Wachtler Hang L., Fischer H., and Svanborg C. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol 39 (2001) 542-552
23. Schilling J.D., Martin S.M., Hunstad D.A., et al. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 pilated Escherichia coli. Infect Immun 71 (2003) 1470-1480
24. Samuelson P., Hang L., Wullt B., Irjala H., and Svanborg C. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun 72 (2004) 3179-3186
25. Scherberich J.E., Schneider J., Nockher A., and Schoeppe W. Excretion of a soluble 48 kDa monocyte membrane antigen in patients with kidney diseases. Kidney Int 43 (1993) 249
26. Kawai T., and Akira S. TLR-signaling. Cell Death Differ 13 (2006) 816-825
27. Scherberich J.E., Schäfer K., Mondorf W., Gauhl C., and Sietzen W. Escherichia coli receptors on human kidney brush-border membranes. Lancet 2 (1977) 1181
28. Scherberich J.E., Jüngst G., Gauhl C., et al. Microbial receptors on human kidney epithelia; a possible clue in the pathogenesis of bacterial interstitial nephritis. Prot Biol Fluids 129 (1982) 603-606
29. Baer P.C., Nockher W.A., Haase W., and Scherberich J.E. Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Kidney Int 52 (1997) 1321-1331
30. Baer P., Scherberich J.E., Bereiter-Hahn J., and Geiger H. Induction of RANTES, HLA-DR, and intercellular adhesion molecule-1 on highly purified distal tubular cells from human kidney. Transplantation 69 (2000) 2456-2459
31. Wolfs T.G.A.M., Buurman W.A., van Schadewijk A., et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: INF-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168 (2002) 1286-1293
32. Bäckhed F., Meijer L., Normark S., and Richter-Dahlfors A. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol 4 (2002) 493-501
33. Bäckhed F., Söderhäll M., Ekman P., Normark S., and Richter-Dahlfors A. Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol 3 (2001) 153-158
34. Tsuboi N., Yoshikai Y., Matsuo S., et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169 (2002) 2026-2033
35. Saemann M.D., Weichardt T., Zeyda M., et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115 (2005) 468-475
36. Spies B., Hochrein H., Vabulas M., et al. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J Immunol 171 (2003) 5908-5912
37. Decker T. Sepsis-avoiding its deadly toll. J Clin Invest 113 (2004) 1387-1389